Home > Financial Ratios > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
EBIT Growth

    Back to All Ratios
BAFNA PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BAFNA PHARMACEUTICALS
Please provide your vote to see the results

BAFNA PHARMACEUTICALS Last 5 Year EBIT Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) -28.58-29.41127.17-8.50468.50

What is the latest EBIT Growth ratio of BAFNA PHARMACEUTICALS ?

The latest EBIT Growth ratio of BAFNA PHARMACEUTICALS is -28.58 based on Mar2025 Standalone results.
Year EBIT Growth
Mar2025-28.58
Mar2024-29.41
Mar2023127.17
Mar2022-8.50
Mar2021468.50

How is EBIT Growth of BAFNA PHARMACEUTICALS Trending?

Years EBIT Growth % Change
Mar2025 -28.58
Negative
Mar2024 -29.41
Negative
Mar2023 127.17
Positive
Mar2022 -8.5
Negative
Mar2021 468.5 -

Other Financial Ratios of BAFNA PHARMACEUTICALS


Compare EBIT Growth ratio of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹366.0 Cr -0.1% 23.9% 78.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹405,452.0 Cr -0.3% 6% -10.5% Stock Analytics
DIVIS LABORATORIES ₹179,089.0 Cr 3.9% 18.6% 14.5% Stock Analytics
CIPLA ₹121,299.0 Cr -5.2% NA 2.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹120,456.0 Cr -1% -1.2% 8.7% Stock Analytics
DR REDDYS LABORATORIES ₹99,965.9 Cr -6.8% -2.1% -8.4% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

-0.1%

23.9%

78.1%

SENSEX

-0.3%

4.5%

5.7%


You may also like the below Video Courses